Invention Grant
- Patent Title: Methods for diagnosing and assessing risk of developing glomerulosclerosis
-
Application No.: US15297804Application Date: 2016-10-19
-
Publication No.: US10858705B2Publication Date: 2020-12-08
- Inventor: Martin Pollak , Elizabeth J. Brown , Johannes Schlondorff
- Applicant: The Brigham and Women's Hospital, Inc. , Children's Medical Center Corporation
- Applicant Address: US MA Boston US MA Boston
- Assignee: The Brigham and Women's Hospital, Inc.,Children's Medical Center Corporation
- Current Assignee: The Brigham and Women's Hospital, Inc.,Children's Medical Center Corporation
- Current Assignee Address: US MA Boston US MA Boston
- Agency: Fish & Richardson P.C.
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6883 ; C12Q1/6811 ; C12Q1/6816 ; C12Q1/6827 ; C12Q1/6813 ; G01N33/68 ; C12Q1/6876 ; C12Q1/6886
Abstract:
This document features method related to variants in the Inverted Formin 2 (INF2) gene that are associated with susceptibility to focal segmental glomerulosclerosis (FSGS). For example, methods of using such variants for risk assessment and for diagnosing and optimizing treatment of FSGS are provided.
Public/Granted literature
- US20170096707A1 METHODS FOR DIAGNOSING AND ASSESSING RISK OF DEVELOPING GLOMERULOSCLEROSIS Public/Granted day:2017-04-06
Information query
